The One in a Million Podcast
from Novartis Canada Medical Affairs
The genetics of autoinflammatory disorders - conversation with Christian Marshall, PhD
You last listened April 19, 2021
With roughly 100 staff, Dr Marshall’s lab provides a large range of genetic testing for many different disorders, where they conduct ~20,000 tests from around the province of Ontario. This pragmatic episode will go over the basics; from the best information to include when ordering a test, to explaining the differences of Sanger and next-generation sequencing. Also – what if a panel test comes back negative: where do we go next? You don’t want to miss this!
Our host, Dr Michelle Batthish (Associate Professor in the Department of Pediatrics' Division of Rheumatology at McMaster University) invites you to listen into the first episode of the first series of the One in a Million Podcast, which will serve as a background and introduction into the world of autoinflammation. In this episode, she sits down with Dr Ron Laxer where they get to the basics of this space.
Dr. Marshall is a Clinical Laboratory Director in the Division of Genome Diagnostics at the Hospital for Sick Children in Toronto, and an Assistant Professor at the University of Toronto. Medical genetics has been the focus of his career, specifically in understanding how genetic variation is associated with disease phenotypes and then translating these associations into diagnostics. Dr. Marshall’s current research focuses on the application of new sequencing technologies for identification of human genome variation causing disease. As a principal investigator for the Centre for Genetic Medicine’s Genome Clinic, he is exploring the diagnostic utility of genome sequencing in pediatric medicine and the translation of the technology into clinical diagnostics.
Dr. Marshall is a Clinical Laboratory Director in the Division of Genome Diagnostics at the Hospital for Sick Children in Toronto, and an Assistant Professor at the University of Toronto. Medical genetics has been the focus of his career, specifically in understanding how genetic variation is associated with disease phenotypes and then translating these associations into diagnostics. Dr. Marshall’s current research focuses on the application of new sequencing technologies for identification of human genome variation causing disease. As a principal investigator for the Centre for Genetic Medicine’s Genome Clinic, he is exploring the diagnostic utility of genome sequencing in pediatric medicine and the translation of the technology into clinical diagnostics.